SEC Form 4 · accession 0001209191-17-002743
LA JOLLA PHARMACEUTICAL CO · LJPC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin C Tang
Director · 10% Owner
Period of report
Jan 4, 2017
Accepted (ET)
Jan 6, 2017 · 5:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $19.19 | Jan 4, 2017 | A | 10,000 | A | — | Jan 4, 2027 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1This option represents a right to purchase a total of 10,000 shares of the Issuer's Common Stock, which shall be fully vested and exercisable on January 4, 2018.